Highlights from the 2022 Society of NeuroInterventional Surgeons 19th Annual Meeting in Toronto, Canada
The SNIS program covered an array of exciting topics related to hemorrhagic and ischemic stroke care, as well as treatment of chronic subdural hematomas and drug delivery. The Treat the Stroke team attended the conference and presented clinical outcomes research for aneurysm treatment. Find our meeting highlights below:
- Women in Neurointervention Leadership: Led by authors Leanne Meyer and Sara Laschever, this day focused on building leadership skills for women neurointerventionalists.
- Neurointerventional stroke treatment: These informative sessions included the treatment of cerebral venous sinus thrombosis, AVM, AVF, and the use of dural and intracranial AV shunts. Treatment and complications in pediatric neurointerventional surgery were also discussed.
- Cerebral aneurysm treatment: The application of innovative technologies including utilization of the Comaneci device (Rapid Medical), latest updates in clinical outcomes related to flow diverters and intrasaccular flow disrupters, and advances in vasospasm management were presented.
- Clinical trials: Novel trials included MMA embolization, flow diversion, venous stenting, and neuroprotection in acute ischemic strokes.
- Artificial intelligence in neurointerventional surgery: Various neurointerventionalists explored the exciting use of robots and AI for endovascular stroke care.
- Neurointerventional education: Neuroanatomy, fellowship preparation, and neurointerventional research topics were taught.
- Subdural hematoma treatment: Presentations focused on the technical nuances and complications related to middle meningeal artery (MMA) embolization for treatment of chronic subdural hematomas.
- Image-guided drug delivery: Led by pioneers in the field, presenters discussed a variety of novel treatments including blood-brain barrier disruption for drug delivery and targeted nanoparticle delivery.